Logo
SearchSearch
Languages
Language
LoginSign up
Invest in AbCellera Biologics Inc.
Today
Create an eToro account to buy ABCL stock on a secure, user-friendly, multi-asset trading platform.
Buy AbCellera Biologics Inc.
ABCL Price
AbCellera Biologics Inc. ABCL
ABCL Price

AbCellera Biologics Inc. ABCL

$2.77-0.23(-7.67%)(1D)

ABCL Stock Price Chart

-5.52%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The AbCellera Biologics Inc. share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The AbCellera Biologics Inc. share price today is 2.77, reflecting a -7.67% change over the last 24 hours and -16.34% over the past week. The current market capitalization of ABCL is 818.16M with an average volume in the last three months of 2.67M. The stock has a P/E ratio of -4.62 and a dividend yield of 0%. With the stock’s beta sitting at 1.31
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$818.16M

Day’s Range
i
Shows the high and low prices of the day.
2.74 - 3.45

52W Range
i
Shows the high and low prices of the last year.
2.31 - 8.03

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
2.67M

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-4.62

Revenue
i
The total income generated by this company’s goods and services last year.
$32.96M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$2.77

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-0.6

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.31

What Is AbCellera Biologics Inc.?
AbCellera Biologics Inc. is a biotechnology firm that engages in researching and developing human antibodies. It was founded in 2012 with its headquarters in Vancouver, Canada. It operates mainly in Canada.

AbCellera studies natural immune systems to find antibodies. Once found, they are decoded and analysed for drug development aimed at overall health improvement. The search for systems is done via the screening of different species. Trianni operates as AbCellera's complete functional human antibody repertoire. Study of the different antibodies along with diverse species has led to breakthroughs in biotechnology and immune profiling. In 2018, AbCellera celebrated the opening of its new research facility and corporate headquarters. As of 31 December 2020, the company has 103 discovery programs that are either completed, in progress, or under contract. It has entered into a discovery partnership agreement with Eli Lilly and Company.

AbCellera uses other biotechnology techniques and equipment to improve its platform, such as Celium, its antibody visualisation and exploration software. The company's customised single-cell assays allow it to convert antibody responses into raw data for further analysis. From that data, it can use repertoire sequencing to nominate solutions for diseases. AbCellera trades on the NASDAQ under the ticker ABCL.

Follow ABCL shares and stay up to date on its value changes here on eToro.

How can I buy AbCellera Biologics Inc. stocks?

To purchase AbCellera Biologics Inc.:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the AbCellera Biologics Inc. (ABCL) page and place an order to buy AbCellera Biologics Inc..
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy AbCellera Biologics Inc.
Invest in AbCellera Biologics Inc.
Today
Create an eToro account to buy ABCL stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of ABCL is 2.77.
The average price target for AbCellera Biologics Inc. is 2.77. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for AbCellera Biologics Inc. based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of AbCellera Biologics Inc. is 818.16M
Scroll to top